aoxin q&m

Q&M Dental subsidiaries propose entering JV to offer laboratory services

The proposed JV will be 49 per cent owned by Q&M Dental (Shenyang) and 51 per cent owned by Singapore Dental Cadcam Laboratory

Aoxin Q&M says it will take action to recover the salary owed by former CEO Dr Shao Yongxin for failing to serve his required six-month notice period.

Aoxin Q&M’s ex-CEO accused of taking 15 million yuan via improper loans, sham share deals

The audit committee has ‘reasonable evidence’ that four whistleblower reports received by the board are credible

Aoxin Q&M posts a 44.8% year-on-year decline in earnings per share to 0.0053 yuan from 0.0096 yuan.

Aoxin Q&M Dental H1 net profit down 44.3% at 2.7 million yuan

Revenue rises 4.6% to 86.8 million yuan, from 83 million yuan in the year-ago period

Dr Shao Yongxin is in the midst of relinquishing all his duties, including his directorships in subsidiary companies in Aoxin Q&M.

Aoxin Q&M suspends former CEO as part of whistle-blowing investigation

The move follows Dr Shao’s resignation on Jul 22 after a whistle-blower report against him was sent to company’s audit committee

Catalist-listed Aoxin Q&M Dental is the Chinese subsidiary of Singapore's Q&M Dental Group.

Aoxin Q&M Dental CEO resigns as whistle-blower report lodged

The company cites ‘differences in views and opinions’ with parent Q&M Dental regarding the direction of the dental business as the reason for Dr Shao Yongxin leaving

Appointment of the IFA follows Q&M Dental Group's offer to acquire the remaining shares it does not already own in Aoxin Q&M at S$0.0321 per share. 

Aoxin Q&M appoints IFA for offer from Q&M Dental Group

Hong Leong Finance will advise the recommending directors on the offer

The development follows Q&M Dental Group’s recent increase in its stake in Catalist-listed Aoxin Q&M from 33.33 per cent to 50.53 per cent.

Q&M Dental makes cash offer for remaining Aoxin Q&M shares at S$0.0321 each

Group says acquisition of Aoxin shares via the security enforcement is aligned with its strategy to expand its assets and earnings

Aoxin’s board says it is seeking legal advice, and will provide its response to the requisition and updates in due course.

Aoxin Q&M’s largest shareholder calls for EGM to oust executive director

Mainboard-listed Q&M Dental Group (Singapore) holds some 32.78% of Catalist-listed Aoxin’s shares

Q&M Dental says Acumen's lab business volume has been "small" since the shift away from PCR testing in Singapore for Covid-19 since late 2022.

Q&M unit’s lab business remains suspended; to shutter Sengkang vaccination centre

It has “no immediate plans” to reapply for its laboratory licence after it expired on Sep 15 this year